Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The left atrial appendage is a small, ear-shaped pouch of muscular tissue projecting from the main body of the left atrium of the heart[1][2][3]. It functions as a decompression chamber and plays a role in the regulation of blood volume by releasing natriuretic peptides when stretched[1]. In atrial fibrillation, it is the primary site for thrombus formation, leading to increased risk of stroke[2]. Devices or procedures to occlude or remove the LAA can reduce stroke risk in certain patients but may transiently affect circulating peptide levels[1]. The LAA is an anatomical structure, not a molecular therapeutic target, receptor, or enzyme[1][3], and is considered for procedural intervention rather than pharmacologic targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Left atrial appendage (LAA).